XML 30 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
OPERATING EXPENSES    
Amortization $ 57,344 $ 57,344
Research and development expenses 341,501 194,521
Selling, general and administrative expenses 307,373 239,562
TOTAL OPERATING EXPENSES 706,218 491,427
LOSS FROM OPERATIONS (706,218) (491,427)
OTHER EXPENSE (INCOME)    
Change in fair value of derivative liabilities (362,586)
Gain on settlement of debt (51,400)
Interest Expense 3,477,615 272
Interest income (20) (428)
TOTAL OTHER EXPENSE (INCOME) 3,115,009 (51,556)
NET LOSS (3,821,227) (439,871)
Deemed dividend 17,099,058 48,659
NET LOSS ATTRIBUTABLE TO COMPANY STOCKHOLDERS $ (20,920,285) $ (488,530)
NET LOSS PER COMMON SHARE, BASIC AND DILUTED $ (0.04) $ 0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED 516,577,125 309,279,009